Navigation Links
A.J. Drexel Autism Institute receives $1.5 million from the Charles and Barbara Close Foundation
Date:3/20/2012

PHILADELPHIA (March 20, 2012) Drexel University has received a gift of $1.5 million from the Charles and Barbara Close Foundation, founded by Drexel alumnus Charles Close ('36), to help establish the A.J. Drexel Autism Institute. The Institute is the nation's first autism center focused on public health science.

"Public health science brings population-focused strategies to autism research. The ultimate goal is to discover, develop and implement approaches for preventing the morbidity and disability associated with autism," said Dr. Marla J. Gold, dean of Drexel's School of Public Health.

Autism is believed to affect at least 700,000, or one in 110, U.S. children and perhaps up to 4 million U.S. adults, many of whom are undiagnosed.

Under the leadership of Dr. Craig Newschaffer, professor and chair of the Department of Epidemiology and Biostatistics, the A.J. Drexel Autism Institute will build capacity to conduct research that addresses the larger picture of autism's impact throughout the lifespan on individuals, families, schools, social service systems and communities.

"Our approach will range from research focused on discovering preventable causes of the morbidity and disability that comes with autism, to work designed to find out how intervention and supportive approaches can be effectively scaled up to do the most good in our communities," said Newschaffer. "Over the next several years we will bring outstanding public health scientists to Drexel to join our Institute team and to partner with the range of organizations in the region that share our commitment to autism."

As the Institute grows, areas of emphasis will include:

  • Environmental risk factor epidemiology and exposure biology: Discovering preventable causes.
  • Early diagnosis and intervention: Finding ways to help children with autism receive services more quickly and efficiently, and spreading the most effective intervention approaches throughout the community, including underserved areas.
  • Adolescent and adult population outcomes: Providing a better understanding of how adolescents and young adults with autism can lead maximally independent and fulfilling lives.
  • Risk communication: Creating new ways to share information about autism that puts scientific accuracy at the forefront but respects community perspectives.

The Institute builds on the faculty, resources and research already at Drexel in bringing a public health approach to autism science. Most notably, the School of Public Health is home to the Early Autism Risk Longitudinal Investigation (EARLI), directed by Newschaffer, which is one of only eleven NIH Autism Center of Excellence projects and the only one built on a public health science approach.

"The emotional and economic costs of autism to our society are enormous," said Drexel president John A. Fry. "Drexel has a responsibility as a leading research university to tackle grave challenges like autism, and I am pleased that the Close Foundation sees the value in our efforts."

Funds from the Close Foundation gift will support recruiting new faculty and development of Institute facilities, including dedicated clinical space, laboratory space, office space and public areas.


'/>"/>

Contact: Rachel Ewing
raewing@drexel.edu
215-895-2614
Drexel University
Source:Eurekalert  

Related medicine news :

1. Hospital safety climate linked to both patient and nurse injuries: Drexel study
2. Drexel study: Misuse of pain medication is pathway to high-risk behaviors
3. Novel mouse model for autism yields clues to a 50-year-old mystery
4. Mothers of Kids With Autism Earn Less, Study Shows
5. Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism
6. From Refrigerator Mothers to untangling the genetic roots of autism
7. Parent Training May Help Kids With Autism Behave Better
8. Study compares traits of autism, schizophrenia
9. Training parents is good medicine for children with autism behavior problems
10. Meds for Autism Not Well Understood: Study
11. UC Davis MIND Institute researchers to present on autism at AAAS Annual Meeting in Vancouver
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A.J. Drexel Autism Institute receives $1.5 million from the Charles and Barbara Close Foundation
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix ... of Emergency Medicine , an emergency medicine professional association, to support the organization's ... , The American Academy of Emergency Medicine, or AAEM, seeks to empower emergency ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Emergency rooms provide ... to find. Unfortunately, this can leave patients with dental emergencies at risk of losing ... now offering emergency dental care. , Common dental emergencies include:, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Jessica Barron, of ... is now accepting new dental patients and families in the North Metro Denver area. ... services from cleanings to cosmetic dentistry, and all in the most relaxing environment. , ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... organization, welcomes S.S. Nesbitt as the latest addition to its growing list of ... other locations throughout the Southeast, from Orlando to Huntsville and in between. , ...
(Date:2/10/2016)... ... , ... Armune BioScience signed a definitive agreement with ARCpoint ... across the country. Launched in April of 2015, Apifiny is the only cancer specific, ... order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... LONDON , February 10, 2016 A new report ... 2021 - states that the Alzheimer,s disease market will more than double ... 2021, at a Compound Annual Growth Rate (CAGR) of 11%. ... Italy , Spain , the UK, and ... prevalence during the forecast period. --> Canada , ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... , Feb. 10, 2016 Immune Pharmaceuticals Inc. ... announced today that it has filed a patent application ... other cancers. --> --> ... by administration of Ceplene (histamine dihydrochloride) in combination with ... of predicting the efficacy of Ceplene and IL-2 therapy ...
Breaking Medicine Technology: